theMednetRegister

Hematology

Stem Cell Transplantation   

Questions discussed in this category



Papers discussed in this category

Blood, 2016-03-31
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Bone marrow transplantation, 2016-07
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.
Bone marrow transplantation, 2018-02
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.
British journal of haematology, 2020 Mar 04
Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.
Blood advances, 2022 Jan 11
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2020 Jan-Dec
A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting.
Bone marrow transplantation, 2022 Dec 23
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study.
Cancer, 2023 Jun 24
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
The New England journal of medicine, 2024 Jun 03
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Nature medicine, 2024 Jun 03
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.
The New England journal of medicine, 2013-02-21
Apixaban for extended treatment of venous thromboembolism.
The New England journal of medicine, 2017 Mar 18
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Related Topics in Hematology

Copyright © 2025 theMednet
All Rights Reserved.